Prudential Financial’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$218K Buy
43,070
+24,280
+129% +$123K ﹤0.01% 2181
2025
Q1
$99.4K Buy
18,790
+2,720
+17% +$14.4K ﹤0.01% 2131
2024
Q4
$109K Hold
16,070
﹤0.01% 2141
2024
Q3
$106K Sell
16,070
-18,415
-53% -$121K ﹤0.01% 2571
2024
Q2
$259K Buy
34,485
+1,515
+5% +$11.4K ﹤0.01% 2406
2024
Q1
$329K Buy
+32,970
New +$329K ﹤0.01% 2307